SBI Securities’s PAVmed PAVM Stock Holding History

SBI Securities’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$247	Hold	67	–	–	﹤0.01%	3344
2026 Q2	$398	Hold	67	–	–	﹤0.01%	3117
2026 Q1	$680	Buy	67 +63	+1,575%	+$596	﹤0.01%	2788
2025 Q4	$24	Hold	4	–	–	﹤0.01%	3740
2025 Q3	$47	Hold	4	–	–	﹤0.01%	3739
2025 Q2	$65	Hold	4	–	–	﹤0.01%	3663
2025 Q1	$78	Hold	4	–	–	﹤0.01%	3527
2024 Q4	$68	Buy	+4	New	+$118	﹤0.01%	3560

Other funds holding PAVM

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Foresight Capital Management Advisors Saline, Michigan $202M AUM 20.26% 1-Year Est. Return

SBI Securities's PAVM Position: Q3 2026 in Review

SBI Securities held its PAVmed (PAVM) position steady in Q3 2026 at 67 shares worth $247. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

SBI Securities first reported a position in PAVM in Q4 2024 and has held it in 8 quarters since. The position peaked at $680 in Q1 2026. 6 funds tracked by Wall St. Rank hold PAVM as of Q3 2026.

SBI Securities held 67 shares of PAVmed worth $247 as of Q3 2026.
SBI Securities left its PAVmed share count unchanged in Q3 2026.
PAVmed made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3344 holding.
SBI Securities first reported a position in PAVmed in Q4 2024 and has held it in 8 quarters since.
SBI Securities's PAVmed position peaked at $680 in Q1 2026.
6 funds tracked by Wall St. Rank held PAVmed as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.